| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
PTGER3 |
PTGER3: Prostaglandin E2 receptor EP3 subtype |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
MC3R |
MC3R: Melanocortin receptor 3 |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
HRH1 |
HRH1: Histamine H1 receptor |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
PTGER1 |
PTGER1: Prostaglandin E2 receptor EP1 subtype |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
HTR1D |
HTR1D, HTR1DA, HTRL: 5-hydroxytryptamine receptor 1D |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
0.265 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GPR45 |
High-affinity lysophosphatidic acid receptor homolog |
0.265 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
CCR6 |
CCR6, CKRL3, CMKBR6, GPR29, STRL22: C-C chemokine receptor type 6 |
0.265 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
CCR10 |
CCR10, GPR2: C-C chemokine receptor type 10 |
0.265 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
PRSS8 |
PRSS8: Prostasin precursor |
0.265 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
0.265 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
KLK7 |
KLK7, PRSS6, SCCE: Kallikrein-7 precursor |
0.265 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
PRSS8 |
PRSS8: Prostasin precursor |
0.265 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
0.265 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
TPSG1 |
TPSG1, PRSS31, TMT: Tryptase gamma precursor |
0.265 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
KLK7 |
KLK7, PRSS6, SCCE: Kallikrein-7 precursor |
0.265 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
MASP1 |
MASP1, CRARF, CRARF1, PRSS5: Complement-activating component of Ra-reactive fact |
0.265 |
Evidence |
|
| SERPINE2 |
SERPINE2, PI7, PN1: Glia-derived nexin precursor |
PRSS8 |
PRSS8: Prostasin precursor |
0.265 |
Evidence |
|
| SERPINE2 |
SERPINE2, PI7, PN1: Glia-derived nexin precursor |
TPSG1 |
TPSG1, PRSS31, TMT: Tryptase gamma precursor |
0.265 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.265 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.265 |
Evidence |
O
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
0.265 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
0.265 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
MASP1 |
MASP1, CRARF, CRARF1, PRSS5: Complement-activating component of Ra-reactive fact |
0.265 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
0.265 |
Evidence |
|